PURELON 1.2 %
Cohesive Ophthalmic Viscosurgical Device (OVD)
Overview
PURELON 1.2% is a cohesive viscoelastic formulation containing 12 mg/mL sodium hyaluronate produced by biofermentation. It combines enhanced viscosity with exceptional clarity, ensuring reliable anterior chamber maintenance and effective corneal protection during cataract and IOL implantation procedures.
Developed for phacoemulsification and micro-incision surgeries requiring balanced elasticity and precise tissue handling.
Technical Specifications
Composition: Sodium Hyaluronate in Phosphate Saline Buffer Colorless, clear, sterile, non-pyrogenic.
HA Concentration: 12 mg/mL (1.2 %)
Molecular Weight: 2.8 – 3.2 Daltons
Classification: Cohesive
Viscosity: 80,000 - 110,000 mPa·s
pH: 6.8 – 7.6
Osmolality: 280 – 400 mOsm/kg
Storage Temperature: +2 °C to +25 °C
Shelf Life: 36 months
Packaging: 0.55 / 0.85 / 1.0 / 1.5 mL prefilled glass syringe in sterile blister – includes patient labels & IFU
Usage Condition: Ready to use — no pre-cooling required
Key Features
Improved space maintenance and chamber stability
Enhanced tissue coating and corneal protection
Smooth, bubble-free injection and easy aspiration
Sterile, pyrogen-free, single-use glass syringe
Recommended Use
PURELON 1.2% provides superior coating and chamber stability, making it suitable for surgeries requiring greater viscosity and longer operating times.
Interested in PURELON 1.2 % for your practice?
Contact us to request product details, technical documents, or distributor information.